checkAd

     364  0 Kommentare CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500 for the Third Consecutive Year

    SOUTH SAN FRANCISCO, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) -- The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its inclusion on the Deloitte Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. This marks the third consecutive year that CareDx has been included on the Deloitte Technology Fast 500.

    Inclusion on the list was based, in part, on CareDx’s strong revenue growth in 2020, which included record revenue of $192.2 million in 2020, an increase of nearly 300% since 2017. For the full year 2021, the company anticipates revenue to be in the range of $290 to $293 million in 2021, representing an expected increase of more than 50% versus last year. Key accomplishments for the quarter ending September 30, 2021, include the extension of the company’s leadership position in transplant centers with the utilization of AlloMap Heart in over 90% of heart centers and AlloSure Kidney in over 70% of kidney centers.

    “Our strong performance further solidified CareDx as the leading transplant company serving the continuum of pre- to post-transplant needs of patients, and we are incredibly proud to be recognized for our efforts on the Deloitte Technology Fast 500,” said Reg Seeto, CEO and President of CareDx. “Recognition on this list for the third consecutive year is a reflection of our unrelenting commitment to transplant patients and focus on furthering innovation, including our significant progress towards pan-organ leadership by being the first company in the space with dd-cfDNA for heart, kidney and lung patients, and the first and only to achieve multi-modality transplant coverage.”

    About the 2021 Deloitte Technology Fast 500

    Now in its 27th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2017 to 2020.

    In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen
    Verfasst von globenewswire
    CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500 for the Third Consecutive Year SOUTH SAN FRANCISCO, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) - CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for …